Proteasome inhibition reverses hedgehog inhibitor and taxane resistance in ovarian cancer.

Steg, Adam D; Burke, Mata R; Amm, Hope M; Katre, Ashwini A; Dobbin, Zachary C; Jeong, Dae Hoon; Landen, Charles N

Steg, Adam D; Burke, Mata R; Amm, Hope M; Katre, Ashwini A; Dobbin, Zachary C; Jeong, Dae Hoon; Landen, Charles N.

Affiliation

Steg AD; Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL. McWhorter School of Pharmacy, Samford University, Birmingham, AL. These authors contributed equally to this work.
Burke MR; Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL. These authors contributed equally to this work.
Amm HM; Institute of Oral Health Research, University of Alabama at Birmingham, Birmingham, AL.
Katre AA; Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL.
Dobbin ZC; Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL.
Jeong DH; Department of Obstetrics and Gynecology Busan Paik Hospital, Inje University, Gimhae, South Korea.
Landen CN; Department of Obstetrics and Gynecology, University of Virginia, Charlottesville, VA. These authors contributed equally to this work.

Oncotarget ; 5(16): 7065-80, 2014 Aug 30.

Article in En | MEDLINE | ID: mdl-25216523

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Pyrazines / Pyridines / Biphenyl Compounds / Boronic Acids / Bridged-Ring Compounds / Antineoplastic Combined Chemotherapy Protocols / Taxoids / Hedgehog Proteins / Proteasome Inhibitors Limits: Female / Humans Language: En Journal: Oncotarget Year: 2014 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google